CSS
CELU icon

Cubist Systematic Strategies’s Celularity CELU Stock Holding History

Cubist Systematic Strategies’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,241
Closed -$13.9K – 3637
2023
Q3 		$13.9K Sell
6,241
-4,193
-40% -$15.1K ﹤0.01% 3125
2023
Q2 		$55.6K Buy
+10,434
New +$66.8K ﹤0.01% 3084
2023
Q1 		– Sell
-832
Closed -$10.7K – 3950
2022
Q4 		$10.7K Sell
832
-1,909
-70% -$35.2K ﹤0.01% 4038
2022
Q3 		$63K Buy
2,741
+1,329
+94% +$40.3K ﹤0.01% 4098
2022
Q2 		$48K Buy
+1,412
New +$115K ﹤0.01% 4104

Other funds holding CELU

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
IIA
IPG Investment Advisors San Diego, California $696M AUM 46.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cubist Systematic Strategies's CELU Position: Q4 2023 in Review

Cubist Systematic Strategies sold out of Celularity (CELU) in Q4 2023, closing a stake of 6,241 shares — an estimated $13.9K sold.

Cubist Systematic Strategies first reported a position in CELU in Q2 2022 and held it in 5 quarters. The position peaked at $63K in Q3 2022. 37 funds tracked by Wall St. Rank hold CELU as of Q4 2023.

  • Cubist Systematic Strategies reported no remaining Celularity position as of Q4 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 6,241 Celularity shares in Q4 2023, an estimated $13.9K.
  • Cubist Systematic Strategies first reported a position in Celularity in Q2 2022 and held it in 5 quarters.
  • Cubist Systematic Strategies's Celularity position peaked at $63K in Q3 2022.
  • 37 funds tracked by Wall St. Rank held Celularity as of Q4 2023.

Based on Cubist Systematic Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.